TY - JOUR T1 - Better Reimbursement Decision-Making Based on Expected Cost-Effectiveness: Using Value of Information Decision Analysis to Improve The Design and Efficacy of A Phase Iii Program for Erlotinib JO - Value in Health PY - 2015/11/01 AU - Mukherjee SC AU - Latimer N AU - Richards P AU - Nixon RM AU - Hall PS ED - DO - DOI: 10.1016/j.jval.2015.09.2616 PB - Elsevier BV VL - 18 IS - 7 SP - A700 EP - A700 Y2 - 2025/05/30 ER -